Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19

  • Karl Messlinger
  • Winfried Neuhuber
  • Arne May

Related Research units

Abstract

Clinical publications show consistently that headache is a common symptom in the coronavirus disease of 2019 (COVID-19). Several studies specifically investigated headache symptomatology and associated features in patients with COVID-19. The headache is frequently debilitating with manifold characters including migraine-like characteristics. Studies suggested that COVID-19 patients with headache vs. those without headache are more likely to have anosmia. We present a pathophysiological hypothesis which may explain this phenomenon, discuss current hypotheses about how the coronavirus SARS-CoV-2 enters the central nervous system and suggest that activation of the trigeminal nerve may contribute to both headache and anosmia in COVID-19.

Bibliographical data

Original languageEnglish
ISSN0333-1024
DOIs
Publication statusPublished - 02.2022
PubMed 34407648